An international team with members from the US, Britain and France using neutrons at the Institut Laue-Langevin in Grenoble, France carried out the first study of interactions between a common clinical inhibitor and the HIV-1 protease enzyme. It provides medical science with the first true picture of how an antiviral drug used to block virus replication actually works, and critically how its performance could be improved. The findings, reported in the iJournal ...Saturday, 17 August 2013
New Areas for Improvement Revealed By Neutron Studies of HIV Inhibitors
An international team with members from the US, Britain and France using neutrons at the Institut Laue-Langevin in Grenoble, France carried out the first study of interactions between a common clinical inhibitor and the HIV-1 protease enzyme. It provides medical science with the first true picture of how an antiviral drug used to block virus replication actually works, and critically how its performance could be improved. The findings, reported in the iJournal ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment